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Paracoccus denitrificans: 
a genetically tractable model 
system for studying respiratory 
complex I
Owen D. Jarman, Olivier Biner, John J. Wright & Judy Hirst*
Mitochondrial complex I (NADH:ubiquinone oxidoreductase) is a crucial metabolic enzyme that 
couples the free energy released from NADH oxidation and ubiquinone reduction to the translocation 
of four protons across the inner mitochondrial membrane, creating the proton motive force for 
ATP synthesis. The mechanism by which the energy is captured, and the mechanism and pathways 
of proton pumping, remain elusive despite recent advances in structural knowledge. Progress has 
been limited by a lack of model systems able to combine functional and structural analyses with 
targeted mutagenic interrogation throughout the entire complex. Here, we develop and present the 
α-proteobacterium Paracoccus denitrificans as a suitable bacterial model system for mitochondrial 
complex I. First, we develop a robust purification protocol to isolate highly active complex I by 
introducing a  His6-tag on the Nqo5 subunit. Then, we optimize the reconstitution of the enzyme into 
liposomes, demonstrating its proton pumping activity. Finally, we develop a strain of P. denitrificans 
that is amenable to complex I mutagenesis and create a catalytically inactive variant of the enzyme. 
Our model provides new opportunities to disentangle the mechanism of complex I by combining 
mutagenesis in every subunit with established interrogative biophysical measurements on both the 
soluble and membrane bound enzymes.
Complex I (NADH:ubiquinone oxidoreductase) is a large, multisubunit, membrane-bound enzyme that cou-
ples the oxidation of NADH and reduction of ubiquinone to the translocation of four protons across the inner 
mitochondrial membrane, or cytoplasmic membrane in prokaryotes, contributing to the proton motive force 
(∆p) that is used to power ATP  synthesis1–3. Complex I is also a key site for cellular reactive oxygen species 
 generation4,5, particularly during ischemia reperfusion  injury6. Due to its essential role in metabolism and energy 
production, mutations in complex I and its associated proteins are the origin of a wide range of neuromuscular 
and metabolic  disorders7,8.
In its most minimal form, as typically found in α-proteobacteria, complex I is composed of 14 conserved 
catalytic ‘core’ subunits; the seven core subunits of the hydrophilic domain catalyze electron transfer from NADH 
to ubiquinone, and the seven core subunits in the membrane domain contain the proton  pumps9,10. The mam-
malian enzyme contains an additional 31 ‘supernumerary’ subunits that have been accumulated during evolu-
tion and are required for assembly, stability or regulation of the  complex11,12. Despite the central importance of 
complex I in oxidative phosphorylation, both the coupling mechanism that captures the energy released from 
the electron transfer reaction and consumes it to drive proton translocation, and the mechanism and pathways 
of the proton pumps, remain elusive.
In the last decade, the ‘resolution revolution’ has resulted in a surge of complex I structural data, espe-
cially resulting from cryoEM analyses, including native enzyme structures from bacteria, yeast, plants and 
 mammals10,11,13–16, and substrate and inhibitor bound  states17–20. These structures, along with molecular dynamic 
 simulations2,21,22, have identified intriguing structural elements and key residues that are likely involved in the 
coupling mechanism and proton transfer pathways. However, probing the catalytic roles of these elements and 
sites further is hindered by lack of model systems that first, are suitable for both functional and structural analy-
ses, and second, allow genetic manipulation of the core membrane domain subunits, which are encoded on the 
mitochondrial DNA in eukaryotes. Robust methods for creating site-directed mutants in the mitochondrial 
encoded proteins in eukaryotes are not yet available, rendering the core membrane domain subunits inaccessible 
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to mutagenesis in model systems such as Yarrowia lipolytica, the popular yeast model system for complex I, as 
well as in mammalian species. Development of an experimentally versatile and fully genetically tractable bacte-
rial model system thus has a crucial role to play in addressing mechanistic questions.
The α-proteobacterium Paracoccus denitrificans is a strong candidate for a bacterial model of the mitochon-
drial enzyme. P. denitrificans is a close relative of the  protomitochondrion23 and its respiratory chain possesses 
similarities to the contemporary mitochondrial chain that are uncommon among other bacterial  species23,24. 
First, P. denitrificans uses ubiquinone-10 as its sole quinone in the cell, the same as used by the human respira-
tory chain and in many mammalian  species23,25. Second, P. denitrificans complex I shares much higher sequence 
similarity with the mammalian complexes, particularly in the hydrophilic domain, than the other bacterial 
models currently in use (Escherichia coli and Thermus thermophilus)26. Third, P. denitrificans complex I pos-
sesses three supernumerary subunits with mitochondrial  homologues26, which are not present in other bacterial 
models. Finally, P. denitrificans is known to form respiratory supercomplexes, including complex I-containing 
 respirasomes27, and its electron transport chain composition matches that of the canonical mitochondrial chain; 
it contains both complex III (cytochrome bc1) and complex IV (cytochrome c oxidase). These features have led 
to P. denitrificans being usefully employed in the past as a model system for studies of complex III and  IV28,29. In 
combination, these observations suggest that P. denitrificans presents exciting opportunities to develop a bacterial 
model system for detailed and comprehensive studies of mitochondrial complex I.
To date, only E. coli and T. thermophilus have been used as bacterial model systems for studying complex I. 
While the first published complex I structure came from T. thermophilus, it has not been utilized widely beyond 
structural work, likely due to the difficulty of growing cells at 70 °C and the challenge of biophysical experiments 
at elevated  temperatures9. In contrast, the E. coli model system has been heavily employed in the functional 
interrogation of complex I. Extensive mutagenesis studies in E. coli have helped identify essential residues in the 
complex, such as conserved glutamate and lysine residues that span the central axis of the membrane domain, 
likely involved in charge  propagation21,30–33. However, much of this work was carried out without the benefits of 
the detailed structural information now available. In addition, despite its wide use, the E. coli system has some 
drawbacks that limit its relevance as a model for the mitochondrial enzyme, particularly when compared to 
P. denitrificans: it uses menaquinone or ubiquinone-8 as a terminal electron  acceptor25, has a lower sequence 
homology than P. denitrificans to the mitochondrial  enzyme26 and E. coli lacks complex III and a cytochrome c 
oxidase and thus cannot form respirasome-like  supercomplexes34.
Perhaps the most appealing aspect of using P. denitrificans complex I to study the enzyme’s catalytic mecha-
nism is that it is possible to form well-coupled energy-transducing vesicles from P. denitrificans membranes, 
a feat that has not yet proved possible for other bacterial or yeast model systems. P. denitrificans sub-bacterial 
particles (SBPs, inverted cytoplasmic membrane vesicles) catalyze NADH-driven ATP synthesis both rapidly and 
efficiently, and they have been utilized to determine the number of protons translocated across the membrane by 
complex I for each NADH oxidized (the proton stoichiometry)35,36. Attempts to apply the same approach to E. 
coli vesicles did not succeed because the vesicles were not sufficiently well coupled and the data did not converge 
to provide a robust stoichiometry value. The only published study of the stoichiometry of the E. coli enzyme 
was only able to report a value of at least  three37. The lack of a robust method to determine the proton pumping 
stoichiometry of E. coli complex I compromises its use, as the stoichiometry is a key biophysical property that 
underpins mechanistic assessment of site-directed mutants.
Here, we present P. denitrificans as a genetically tractable model system that can be used to generate and 
study mutations in every core subunit of complex I. Despite being considered unstable when not associated 
with its  supercomplex27, a four-column purification strategy for purifying intact complex I from P. denitrificans 
(Pd-CI) has been described  previously26. Here, we describe a robust, streamlined two-step purification to isolate 
catalytically active P. denitrificans complex I using a genetically engineered affinity tag. Following characteriza-
tion of the pure enzyme, we describe its reconstitution into liposomes to demonstrate that it remains coupled 
and retains proton pumping activity. Finally, we describe a P. denitrificans strain engineered to be amenable to 
the creation of deleterious complex I variants, produced by introducing an alternative NADH dehydrogenase 
as an artificial bypass for complex I essentiality. A point mutation in a conserved charge residue of the Nqo13 
(ND4) subunit was then created and confirmed to possess no catalytic activity, demonstrating the versatility 
and capability of our system.
Results
Insertion of a  His6-tag into the complex I operon. To develop a robust protocol for isolating complex 
I from P. denitrificans we introduced an affinity purification tag onto the C-terminus of the Nqo5 (NDUFS3) 
subunit. The affinity tag contained six histidine residues attached to the Nqo5 subunit by six alanine linker 
residues. The same tag, on the homologous subunit, has been used to purify complex I from the yeast model Y. 
lipolytica17,38,39. Here, we introduced an unmarked insertion of the  His6-tag into the chromosomal DNA of P. 
denitrificans strain Pd1222-∆Hy35 by suicide vector-mediated homologous recombination, an approach previ-
ously used to create unmarked deletions in the P. denitrificans genome (see “Materials and methods”)35,40,41. 
The genetic modification was supported by expression of an alternative NADH dehydrogenase (NDH-2), as 
discussed in detail below. The correct and specific insertion of the purification tag on nqo5 was confirmed by 
sequencing, and the sequences of the all known complex I subunits were checked in the final strain. We refer 
to this strain, which is formally termed Pd1222-∆Hy-Nqo5His6, as Pd-Nqo5His6. Expression of the tagged Nqo5 
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Purification of complex I from P. denitrificans. To purify P. denitrificans complex I, membranes were 
prepared from P. denitrificans cells grown aerobically on LB medium. The conditions for membrane solubiliza-
tion with n-dodecyl β-D-maltoside (DDM) and the buffer compositions were based on those of Yip et al., with 
Bis–Tris replaced by MES and our affinity chromatography buffers supplemented with 0.02%  asolectin26,42. Fol-
lowing solubilization, the proteins were loaded onto a Ni-affinity column and complex I eluted using 200 mM 
imidazole (see "Materials and methods" for details) (Fig. 1a). Complex IV coeluted with complex I, so the eluent 
was further separated by size exclusion chromatography; only the first peak exhibited complex I flavin site activ-
ity (NADH:APAD+ oxidoreduction) and it was thus assigned to complex I (Fig. 1b). The complex I peak eluted 
at the volume expected for intact Pd-CI, as predicted from the eluted volumes of standard proteins given in the 
manufacturer’s guide (Cytiva). The purified enzyme contained 1.50 ± 0.13  Q10 molecules per complex I (S.E.M., 
n = 3 samples from three independent cultures and purifications), which is similar to the ubiquinone content 
measured for the purified E. coli enzyme (1.3 ± 0.1)43. The Pd-CI was analyzed by SDS-PAGE and prominent 
bands were excised, digested with trypsin and the proteins identified by mass spectrometry analyses (Fig. 1c). All 
the core complex I subunits were identified, apart from Nqo7 and Nqo11, which are likely missed from the anal-
ysis due to their small and hydrophobic nature (SI Table S1). Further to the core subunits, the three previously 
identified supernumerary subunits (PdNUMM, PdNUYM, PdN7BM) were also  detected26. Our mass spectrom-
etry analyses also identified several additional proteins with varying degrees of confidence (SI Table S1). Most 
of these are likely minor contaminants and unlikely to be associated with complex I, such as elongation factor 
Tu, transcription termination factor Rho and subunits from other respiratory complexes. A small number of 
other proteins were identified, notably a protein-L-isoaspartate O-methyltransferase (23.5 kDa), which cannot 
be either excluded from or assigned to complex I at the current time. Structural studies will be required to deter-
mine whether these are impurities or unique subunits associated with the P. denitrificans enzyme.
EPR characterization of purified complex I. In order to compare the electron transfer pathways in 
Pd-CI and its mammalian counterpart, electron paramagnetic resonance (EPR) spectroscopy was performed. 
Previous EPR studies of Pd-CI have been limited to membrane  particles44–46, which make deconvolution of 












































































Figure 1.  Purification and subunit composition of P. denitrificans complex I. (a) Typical Ni-affinity 
chromatography trace produced using a HisTrap HP column. The column was washed with 80 mM imidazole 
and protein eluted with 200 mM imidazole. (b) Typical size exclusion chromatography trace using a Superdex 
200 increase 5/150 GL column. Complex I was identified by measuring the relative NADH:APAD+ activity in 
eluted fractions (black trace). (c) SDS-PAGE analysis of purified P. denitrificans complex I. Two full-length lanes 
are shown from a single gel; the image has been cut and they have been moved to be adjacent to each other. The 
original image is shown in SI Fig. S6. Individual complex I subunits were identified and assigned by excising 
each band, treating the sample with trypsin and analyzing the resultant peptides by mass spectrometry. Peptides 
were assigned to a subunit/protein by peptide mass fingerprinting.
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the CI specific signals difficult. EPR spectra of the NADH-reduced purified Pd-CI were measured at different 
temperatures (Fig. 2a). The spectra clearly show the presence of four reduced FeS clusters (N1b, N2, N3 and 
N4), confirming the integrity of the hydrophilic domain in the purified enzyme. At 40 K, a single axial FeS clus-
ter corresponding to the slow-relaxing [2Fe-2S] N1b is observed. As the temperature is decreased, additional 
[4Fe-4S] FeS signals appear in accordance with the established relaxation properties for mammalian complex 
I (N1b < N2 < N3 < N4)47,48. At 7 K, the FeS signals from N2 and N4 are largely saturated. The fast-relaxing N5 
cluster was not observed during these experiments as high power and low temperature are typically required to 
resolve its signal; however, overexpression of the P. denitrificans Nqo3 (NDUFS1) subunit in E. coli has previ-
ously given rise to a signal attributable to  N549.
A simulation of the Pd-CI EPR spectrum recorded at 16 K, using an equal stoichiometry of the four observed 
FeS clusters, is shown (Fig. 2b). This ‘signature’ spectrum for Pd-CI shows remarkable similarity to that observed 
for mitochondrial complex I from Y. lipolytica, which could also be simulated with an equal stoichiometry for the 
same four reduced  clusters50. In contrast, mammalian complex I exhibits sub-stoichiometric reduction of N1b 
when NADH is used as a reductant, owing to its low reduction  potential48. As in both of these mitochondrial 
complexes, but unlike in complex I from E. coli, the [2Fe-2S] cluster in Nqo2 (NDUFV2), referred to as N1a, is 
not reduced in NADH treated Pd-CI. In E. coli complex I, N1a is a high potential cluster that is reduced during 
turnover whereas N3, which is fully reduced by NADH in both mitochondrial and Pd-CI, appears to be reduced 
sub-stoichiometrically51,52. The EPR signal for N1a has thus far only been observed in overexpressed Pd-Nqo2 
reduced with sodium dithionite, with rhombic geometry and characteristic g values of 2.00, 1.94 and 1.9253,54 
that are clearly not present in Fig. 2a. The absence of the reduced N1a signal is consistent with its reduction 
potential being below that of  NADH54,55, and with data on mammalian complex I that show reduction of N1a 
only in the dithionite-reduced flavoprotein subcomplex, not in the intact  enzyme48,55,56. The properties of the 
[2Fe-2S] N1a cluster and pattern of FeS cluster reduction thus further establish the close similarity between 
Pd-CI and mitochondrial complex I.
Catalysis by isolated (detergent-solubilized) P. denitrificans complex I. The integrity and cat-
alytic competence of the complex I isolated from P. denitrificans were determined by measuring its catalytic 
activity. The optimized assay conditions previously described for Pd-CI by Yip et al. were confirmed  here26: the 
activity was highest in buffer at pH 6.5 and in the presence of divalent cations,  Mg2+ or  Ca2+ (SI Fig. S2). The 
addition of sucrose (to make the buffer more hypertonic) had no effect on activity. Under optimal assay condi-
tions, our preparations of Pd-CI were able to catalyze the reduction of 200 µM decylubiquinone (DQ) by NADH 
at typically 21.9 ± 4.2 µmol  min–1  mg–1 (~ 204  s–1, S.D. from 11 independent purifications). For comparison, the 
purified bovine, ovine and Y. lipolytica enzymes have been reported to catalyze the reduction of 200 µM DQ at 
Figure 2.  EPR spectra of NADH-reduced purified complex I from P. denitrificans. (a) Complex I (5.8 mg  mL–1) 
was reduced anaerobically with 15 mM NADH. EPR spectra were recorded at 100 kHz modulation frequency 
with a modulation amplitude of 7 G and a microwave power of 2.02 mW at the temperatures indicated. Vertical 
lines correspond to the g factors for the individual FeS clusters. (b) Simulation of the EPR spectrum of purified 
Pd-CI at 16 K. The total simulation of the combined FeS cluster signals is shown in red, with the individual 
simulations labelled according to the established nomenclature. FeS clusters N1b-N4 were simulated at a 1:1 
ratio. Simulation parameters are given in SI Table S2.
5
Vol.:(0123456789)
Scientific Reports |        (2021) 11:10143  | https://doi.org/10.1038/s41598-021-89575-9
www.nature.com/scientificreports/
22.2–24.7 µmol  min–1  mg–1 (~ 390  s–1)57, 5–6 µmol  min–1  mg–1 (~ 90  s–1)20 and 13.9 µmol  min–1  mg–1 (~ 208  s–1)17, 
respectively, and the bacterial enzyme from E. coli to catalyze reduction of 100 µM DQ at 20–25 µmol  min–1  mg–1 
(~ 206  s–1)43,58. The activities of two soluble quinone analogues,  Q1 and DQ, were then compared on the same 
enzyme preparation (Fig. 3a). Pd-CI catalyzed DQ reduction to higher rates than Q1 reduction, however, the 
high KM values observed for both DQ (169 ± 15 µM) and  Q1 (124 ± 8 µM) suggest that neither is a good substrate 
for the P. denitrificans enzyme. It is worth noting that DQ and  Q1 have limited solubility in aqueous solution and 
so activity data recorded at high substrate concentrations, where they tend to aggregate or form micelles, may 
not provide an accurate picture. Unless otherwise stated, activities reported here were measured using 200 µM 
DQ, to match standard data on the bovine  enzyme57.
To estimate the Q-reductase activity of native Pd-CI in the membrane, and thus the highest possible activity 
we may achieve for the purified enzyme, we compared activities in the membranes with those of the soluble 
form. The membranes and isolated enzyme were able to catalyze flavin-catalyzed NADH:APAD+ oxidoreduc-
tion at 0.497 ± 0.015 µmol  min–1  mg–1 and 9.98 ± 0.05 µmol  min–1  mg–1, respectively (S.E.M. of three techni-
cal replicates). By assuming that the flavin site activity is fully retained during purification, and that the only 
NADH:APAD+ activity in the membrane is from complex I, the complex I content of the membranes was 
estimated at 5.0 ± 0.2% (by protein mass). The membranes were able to catalyze NADH:O2 oxidoreduction at 
2.02 ± 0.09 µmol  min–1  mg–1, which translates to a Q-reductase activity of 40 ± 2 µmol  min–1  mg–1, based on the 
estimated complex I content. Therefore, our rate of DQ reduction suggests we have retained 54 ± 11% of the 
Q-reductase activity in our preparation – although greater activities may be observed at higher concentrations 
of DQ, or by using the native  Q10 as the electron acceptor. Overall, these data provide clear evidence that our 
preparation of Pd-CI is highly active for NADH:ubiquinone oxidoreduction.
The sensitivity of the purified enzyme to the canonical complex I inhibitors piericidin A and rotenone was 
then determined (Fig. 3b). The NADH:DQ activity was inhibited ≥ 90% by piericidin A and rotenone. How-
ever, the enzyme was more sensitive to piericidin A  (IC50: 72 ± 7 nM) than rotenone  (IC50: 2226 ± 185 nM). A 
previous study has also shown that, unlike the mitochondrial enzyme, Pd-CI is poorly inhibited by  rotenone59. 
Surprisingly, Pd-CI purified by Yip et al. was reported to exhibit similarly high sensitivities to both rotenone 
 (IC50: 170 nM) and piericidin A  (IC50: 100 nM)26. These values do not agree with our data or with previous data, 
despite our similar buffer and assay conditions. The enzyme preparation of Yip et al. was reported to have a 
lower activity (15.0 µmol  min–1  mg–1) than ours (21.9 µmol  min–1  mg–1), although it was assayed with a lower 
concentration of DQ. In addition, we note our preparation time was much shorter (hours vs. days), so it is pos-
sible we have maintained greater structural integrity at known rotenone binding sites in the Q-channel and near 
the transverse  helix20.
Finally, we assessed the rate of  H2O2 generation by our purified enzyme using the horseradish peroxidase-
dependent oxidation of Amplex Red to resorufin (see "Materials and methods"). The Amplex Red system detects 
the  H2O2 formed, either directly or by the dismutation of superoxide, assisted by the presence of SOD.  H2O2 was 
generated at 138.6 ± 1.1 nmol  min–1  mg–1 (78  min–1) using 30 µM NADH to activate superoxide/H2O2 production 
at the flavin site, approximately four times faster than generated by the purified complex I from bovine heart 
mitochondria (21.1 ± 2.9 nmol  min–1  mg–1, 21  min–1)60. However, the different pH values at which the two assays 
were performed (pH 6.5 vs. pH 7.5) may also influence the rate of  H2O2  production60.
Optimization of the reconstitution of Pd-CI into liposomes. To study proton pumping of wild-
type and mutated Pd-CI in a controlled minimal membrane environment, the purified enzyme needs to be 
reconstituted into a compartmentalized membrane system that supports formation of a ∆p. We have established 
protocols for the assembly of proteoliposome (PL) systems comprising mitochondrial complex I, ubiquinone 
 Q10, and Trypanosoma brucei brucei alternative oxidase (AOX), which re-oxidizes ubiquinol  Q10H2 to ubiqui-
none  Q10 and reduces oxygen to  water61,62. The system was later expanded to couple ∆p formation by complex 















































Figure 3.  Characterization of purified complex I from P. denitrificans. (a) KM curve for DQ and  Q1 substrates 
for a typical sample of soluble complex I. The KM values for DQ and  Q1 are 169 ± 15 and 124 ± 8 µM, respectively 
(± S.E. of the fit). (b) Piericidin A and rotenone  IC50 titration curves for soluble complex I, using DQ as the 
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topic membrane protein that associates spontaneously to the liposomal membrane and thus it was added after 
reconstitution (to the mature proteoliposomes) in all experiments. Here, we adapted a protocol optimized for 
mammalian  CI63 for the efficient incorporation of Pd-CI. As soluble Pd-CI was found to be most active at pH 
6.5 (SI  Fig.  S2a), the pH of the reconstitution buffer was adjusted to pH 6.5 with MES replacing MOPS as 
the buffering component. Reconstitution of Pd-CI into our standard liposomes that mimic the mitochondrial 
inner membrane lipid composition (80:10:10 dioleoyl phosphocholine (DOPC):dioleoyl phosphoethanolamine 
(DOPE):tetraoleoyl cardiolipin (TOCL), in % (w/w)) for the reconstitution of mitochondrial  CI61,63,64, resulted in 
only low activities of 7.08 ± 0.63 μmol NADH  min-1  mg-1 (n = 8) compared to NADH:Q10 oxidoreduction activi-
ties of up to 40 ± 2 µmol  min–1  mg–1 estimated for Pd-CI in membranes. Thus, we amended the lipid mixture 
to more closely mimic the reported lipid composition of exponentially growing P. denitrificans65, to 52 dioleoyl 
phosphoglycerol (DOPG):37 DOPC:8 DOPE:3 TOCL. Although this did not affect the activity of reconstituted 
Pd-CI (SI Fig. S3a) we adopted it for all further experiments. Significantly increased activities were subsequently 
observed (SI Fig. S3a) when 250 mM sucrose was included in the reconstitution and catalytic assay buffers (see 
below). Next, the amount of AOX was varied to achieve optimal turnover (SI Fig. S3b). The optimal amount of 
AOX was found to be 40–80 µg  mL–1 AOX per 0.5 µg  mL–1 outward facing Pd-CI, which translates to 1200–2400 
molecules of AOX added (to the cuvette) per Pd-CI. These optimized conditions were used for all further experi-
ments.
Characterization of Pd-CI proteoliposomes. The reconstitution protocol optimized for Pd-CI activ-
ity led to a random orientation of Pd-CI in the membrane, with 46.7 ± 16.8% (n = 9, S.D., nine reconstitutions 
using Pd-CI from four different preparations) of the NADH:APAD+ oxidoreductase activity on the outside of 
the proteoliposomes, reflecting around half of the Pd-CI being inserted in an outward facing orientation. As 
NADH is membrane impermeable, the inward facing CI is catalytically silent in kinetic assays. The average 
protein retention (relative to the amount added at the start of the preparation) was determined as 36.9 ± 12.7% 
(n = 10, S.D.). The average NADH:O2 activity (for outward facing Pd-CI) for a standard preparation was 
24.5 µmol  min–1  mg–1 ± 8.4 µmol  min-1  mg-1 (n = 11, S.D.). However, the NADH:O2 activity varied substantially, 
from, 13.8 to 41.5  µmol   min–1   mg–1, with more than 50% of the preparations giving activities between 22.6 
and 26.6 µmol  min–1  mg–1. Only small respiratory control ratios (RCRs) of 1.2 ± 0.2 (n = 8, S.D.), similar to our 
observations for bovine CI  PLs61, were measured. Comparing the average NADH:O2 activity to our estimate 
for the Q-reductase activity of native Pd-CI in the membranes, 61 ± 15% of the total activity is retained during 
purification and reconstitution of Pd-CI.
The KM for the reduction of native ubiquinone  Q10 was measured in Pd-CI PLs (Fig. 4a, in which all the data 
points are from individual reconstitutions and determinations). The KM value of 1.1 ± 0.2 mM for ubiquinone  Q10 
is within the range (0.48–3.94 mM)61–63 of experimentally determined  Q10 KM values for bovine CI, indicating 
similar affinities for  Q10 for both enzymes. The inhibitor titrations for piericidin A and rotenone carried out with 
the soluble enzyme were repeated in Pd-CI proteoliposomes to investigate how the membrane affects the inhibi-
tion (Fig. 4b). The  IC50 values for both inhibitors were decreased in PLs from 2226 ± 185 nM to 452 ± 48 nM and 
from 72 ± 7 nM to 24 ± 3 nM for rotenone and piericidin A, respectively. This is likely due to the smaller hydro-
phobic phase volume in the PL measurements, which concentrates the inhibitor in the vicinity of the enzyme. 
However, the same trend of weaker inhibition by rotenone than piericidin A was confirmed. Pd-CI appears to 
not bind canonical inhibitors of complex I, particularly rotenone, as strongly as the mitochondrial enzymes do. 
Understanding the fundamental differences in inhibitor binding will require structural work and comparison 
to known piericidin A and rotenone-bound complex I  structures18–20.
Next, it was tested whether NADH oxidation is coupled to proton pumping in liposome-reconstituted Pd-CI 
by using the standard fluorescence quench assay, ACMA (9-amino-6-chloro-2-methoxyacridine) quenching 
(Fig. 4c)61. Addition of NADH to Pd-CI-AOX PLs led to a rapid quench of the fluorescence signal indicating 
formation of a ΔpH. Addition of the uncoupler alamethicin dissipated the ΔpH, while empty liposomes did 
not show any fluorescence quench upon NADH addition. The addition of piericidin A to the liposomes also 
prevented fluorescence quenching after NADH addition by inhibiting catalysis and proton pumping (SI Fig. S4). 
In a separate experiment, Pd-CI was co-reconstituted with E. coli ATP synthase into liposomes to test if a sub-
stantial ∆p is being produced by the Pd-CI (Fig. 4d). Indeed, addition of NADH to CI-AOX-F1FO PLs coupled 
NADH oxidation (and ubiquinone reduction) to proton pumping, establishing a ∆p high enough to drive ATP 
synthesis. No ATP was produced when NADH was added to proteoliposomes containing only E. coli ATP syn-
thase, and ATP synthesis in CI-AOX-F1FO PLs was inhibited by piericidin A, or when the ∆p was collapsed by 
the uncoupler gramicidin A. Together these results indicate specific reconstitution of intact Pd-CI into sealed 
liposomes, which couple NADH oxidation to ∆p formation, and demonstrate its proton pumping capability. 
Therefore, our reconstitution protocol can be applied to aid study of the proton pumping mechanism of mutant 
and wild-type CI in future experiments.
A genetic system to study complex I variants. Complex I is essential for the survival of P. denitrifi-
cans cells, preventing the creation of severely deleterious complex I variants. To overcome this issue, Finel and 
coworkers inserted the alternative NADH dehydrogenase (NDH-2) from E. coli directly into the P. denitrificans 
genome to compensate for loss of activity in variants generated in the Nqo8 (ND1)  subunit66,67. Here, we intro-
duced ndh2 from E. coli into P. denitrificans on the inducible expression vector  pLMB50968. Using this approach, 
we could control whether or not NDH-2 was expressed by including the inducer, taurine, in the growth medium, 
allowing us to generate deleterious complex I mutants. The tunability of the system means that we are also able 
to turn off NDH-2 expression to prevent it interfering with activity measurements on non-deleterious mutants. 
The complex I specific substrate deaminoNADH (dNADH), which is not oxidized by NDH-2, can be used in 
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those cases where NDH-2 is required for cell growth. To show that expression of NDH-2 allows cells to grow 
when complex I catalysis is severely compromised, we grew P. denitrificans cells in succinate media and inhibited 
complex I with piericidin A in both cells expressing or not expressing NDH-2 (Fig. 5a). While the addition of 
piericidin A severely limited cell growth, the expression of NDH-2 rescued it to near untreated levels: the cells 
remain viable despite a severely compromised complex I.
To demonstrate the application of our system, we generated a complex I variant that we expected would abol-
ish catalytic activity. We chose to remove the charge from the conserved charged residue Lys232 in the Nqo13 
(ND4) subunit by mutation to a Gln residue  (K232QNqo13). Mutation of the equivalent residue in E. coli to Ala 
rendered complex I  inactive69. The mutation was generated using a method similar to that used to insert the 
affinity purification tag. Crucially, NDH-2 was expressed throughout the growth protocol, essential for successful 
mutagenesis. The  K232QNqo13 mutant was confirmed by sequencing and the cells were only able to grow when 
expressing NDH-2. Membranes were prepared for the  K232QNqo13 mutant from cells expressing NDH-2 and 
the activities of the membranes were measured using dNADH. While the dNADH:APAD+ activity was similar 
between the wild-type (i.e. Pd-Nqo5His6) and  K232QNqo13, the quinone reductase activity was abolished in the 
mutant (Fig. 5b,c). We further characterized the mutant by first purifying  K232QNqo13 and then reconstituting it 
into liposomes. The  K232QNqo13 mutant purified as normal, showed essentially identical elution profiles to wild-
type on the size exclusion column, and a matching band pattern to wild-type in SDS-PAGE analyses (SI Fig. S5). 
These observations suggest that the structural integrity of the mutant was maintained throughout purification 
and its loss of activity has a mechanistic basis rather than being due to structural instability. Both the soluble 
enzyme and the proteoliposomes showed similar relative activities to those measured in membranes (Fig. 5b,c) 





























































































Figure 4.  Characterization of Pd-CI in liposomes. (a) KM curve for  Q10 in proteoliposomes. The KM and Vmax 
values were determined to be 1.1 ± 0.2 mM and 27.9 ± 1.2 µmol  min–1 (mg CI)–1, respectively (± S.E.M. of 
the fit). (b) Inhibition by piericidin A and rotenone. The measured  IC50 values for piericidin A and rotenone 
were 24 ± 3 nM and 452 ± 48 nM, respectively (± S.E. of the fit). (c) Proton pumping measured by an ACMA 
fluorescence quench assay. Proton pumping was initiated by addition of 1 mM NADH and proteoliposomes 
uncoupled by addition of 25 µg  mL–1 alamethicin (AlaM). Liposomes without Pd-CI were added as a control. (d) 
Coupling Pd-CI catalysis to ATP synthesis. Pd-CI was co-reconstituted in liposomes with E. coli ATP synthase 
(CI-AOX-F1FO) and NADH-coupled ATP production was measured as luminescence using a luciferase-based 
assay. No ATP was generated by proteoliposomes containing only ATP synthase  (F1FO only) while addition of 
2 μM piericidin A (pierA) or 20 μg  mL–1 gramicidin A (gramA) inhibited ATP synthesis. Alternative oxidase 
(AOX) was directly added to the assay mixture at 20 µg  mL–1 in panels (a–c) and at 5 µg  mL–1 in panel (d). See 
“Materials and methods” for the assembly of proteoliposomes and other assay conditions.
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and consequently proteoliposomes of the  K232QNqo13 mutant showed no proton pumping activity as measured 
by ACMA (SI Fig. S4).
Discussion
In order to answer long-standing questions about the energy coupling and proton translocation mechanisms of 
respiratory complex I, functional and structural analyses should be combined with targeted mutagenic inter-
rogation of specific residues and protein features. The α-proteobacterium P. denitrificans, a close relative of the 
protomitochondrion, is thus a prime candidate for a model system that could be exploited to unlock the catalytic 
mechanism of mitochondrial complex I, as it enables all three approaches. In addition to the similarities Pd-CI 
possesses with the mitochondrial enzyme that are uncommon in other bacterial models  (Q10 as an electron 
acceptor; higher subunit sequence homology; supernumerary subunits and complex I-containing supercom-
plexes), it is possible to form well-coupled SBPs as a powerful tool for insightful biophysical and biochemical 
characterization. In particular, using SBPs, we have already established a method that can be used to determine 
the number of protons translocated across the membrane by complex I for every NADH oxidized (the proton 
stoichiometry)35,36. Thus P. denitrificans provides an exciting platform to combine site-directed mutagenesis with 
biochemical and biophysical measurements essential for gaining mechanistic insight into complex I.
Here, we establish the potential of P. denitrificans as a suitable bacterial model for mitochondrial complex I. 
First, an affinity purification tag was engineered onto the Nqo5 subunit, allowing reproducible and straightfor-
ward purification of intact, catalytically active complex I. The reconstitution of the detergent-solubilized complex 
into liposomes was then optimized, demonstrating that the complex I retained proton pumping activity. The two 
protocols allow Pd-CI to be studied in both its soluble form and when reconstituted in a controllable minimal 
membrane system, providing a complementary perspective to that which can be gained from well-established 
measurements in SBPs. Second, we created a strain of P. denitrificans that is fully genetically tractable to complex 
I mutagenesis. As complex I is essential to growth of P. denitrificans, its mutagenesis was otherwise limited by the 
inability to create catalytically inactive or compromised variants that would kill the cell. By introducing NDH-2 
from E. coli into P. denitrificans on a taurine-inducible expression plasmid, we were able to show cell survival and 
growth when complex I was compromised, by expressing NDH-2. By creating a catalytically inactive complex 
I variant by a mutation in the Nqo13 subunit we demonstrate the power of our approach, both in being able to 
generate mutations in the membrane domain, not currently routinely possible in mitochondrial models, and 
being able to target even essential residues, regardless of their loss of activity.
Despite the many advantages of using P. denitrificans as a model for mitochondrial complex I, some current 
technical limitations should be noted. Our approach generates unmarked mutations in the P. denitrificans genome 
which, while beneficial as it ensures complex I variants will be constitutively expressed, is more technically chal-
lenging/slower than introducing mutations on a gene expressed on a plasmid, as employed in Y. lipolytica39 or E. 
coli21,30. Further to this, the high GC content of the P. denitrificans genome requires careful consideration during 
even basic cloning procedures. Perhaps the most obvious limitation is that there is no P. denitrificans complex 
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Figure 5.  Creation of a catalytically inactive complex I variant. (a) Growth of wild-type P. denitrificans in 
succinate minimal  media40,41. Cells were grown with/without 10 mM taurine to induce NDH-2 expression and 
with/without 5 µM piericidin A to inhibit complex I and cell growth. (b) Comparison of the complex I flavin 
site activity (NADH:APAD+) of wild-type and the  K232QNqo13 variant measured in three different contexts. 
Membrane activities were measured using dNADH due to the expression of NDH-2 during cell growth. The 
specific activities have been normalized to the wild type activities; in membranes (0.527 ± 0.006 µmol  min–
1  mg–1, S.E.M. n = 3), purified CI (12.13 ± 0.14 µmol  min–1  mg–1, S.E.M. n = 4), and proteoliposomes 
(10.71 ± 0.12 µmol  min–1  mg–1, S.E.M. n = 3). (c) Comparison of the quinone reductase activity  (Q10 or DQ) 
of wild-type and the  K232QNqo13 variant measured in three different contexts. The specific activities have 
been normalized to the wild type activities (minus the average piericidin A insensitive rates) in membranes 
(2.41 ± 0.02 µmol  min–1  mg–1, S.E.M. n = 3), purified enzyme (19.73 ± 0.058 µmol  min–1  mg–1, S.E.M. n = 3), and 
proteoliposomes (41.45 ± 0.17 µmol  min–1  mg–1, S.E.M. n = 3).
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I structure yet available, a crucial element that is required to fully realize its potential as a model for combining 
both functional and structural data with mutagenesis. Although we have demonstrated we can isolate intact 
and highly active complex I from P. denitrificans, the lack of stabilizing supernumerary subunits in the bacterial 
enzyme likely decreases its stability compared to its mitochondrial counterparts. This possibility may explain 
the relative lack of bacterial complex I structures solved by cryo-EM to date. It is known that P. denitrificans 
complex I dissociates under Blue-Native PAGE  conditions27 despite remaining intact during solubilization and 
in our two-step purification, and the freezing methods used in cryo-EM grid preparation may also be detrimen-
tal. A potential alternative route to the P. denitrificans complex I structure may be isolation of the respiratory 
supercomplex, which is known to stabilize Pd-CI and can be visualized on Blue-Native  PAGE27. Although we are 
confident in expecting the enzyme to have a similar overall architecture to current models, and the positions of 
key conserved residues to be in similar configurations, pursuit of the P. denitrificans complex I structure will be 
both beneficial and complementary to the work described here.
As described above, complex I from P. denitrificans possesses many similarities to the mitochondrial enzyme, 
making it an attractive model system. However, there are also fundamental differences between the two that 
can be considered both beneficial and disadvantageous. An important property of mitochondrial complex I is 
that it can undergo an active/deactive (A/D)  transition13,57,70 in which the deactive state cannot catalyze quinone 
reduction and the enzyme is considered to be in an off-pathway resting state. The deactivate state is identified 
biochemically by the binding of N-ethylmaleimide (NEM) to a conserved cysteine residue in Nqo7 (ND3) that 
is only exposed in the deactive state, locking it in this state. P. denitrificans has not been observed to undergo an 
A/D  transition46,70 and here we also tested whether Pd-CI could be deactivated in membranes by assaying the 
membrane activity in control and heat-treated membranes (conditions which deactivate the mouse and bovine 
 enzymes13,57) with and without NEM. We observed no differences in activity to suggest the enzyme is able to 
form an (NEM-sensitive) deactive state (SI Table S3). Hence, Pd-CI cannot be used as a model to assess or 
investigate the A/D transition that occurs in mitochondria, which may be a unique feature of the mitochondrial 
enzyme. However, Pd-CI can instead be considered a model for the ‘active’ mitochondrial enzyme, which is an 
advantage for studies of the mechanism of catalysis as the effects of mutations in catalytically relevant residues 
can be deconvoluted from possible effects on the A/D transition in the mitochondrial enzyme. In this regard, as 
well as in many others, P. denitrificans is a powerful system for probing the mechanism of complex I catalysis.
Materials and methods
Chemicals. All chemicals were purchased from Sigma-Aldrich unless stated otherwise.
Creation of bacterial strains. Insertion of NDH-2 into P. denitrificans. The NDH-2-encoding gene from 
E. coli (ndh2) was optimized for the codon usage in P. denitrificans and the construct synthesized by GENEWIZ®. 
Two restriction sites were added to the 5ʹ (NsiI) and 3ʹ (SacI) ends of the construct, which was then digested 
and inserted into the expression vector pLMB509 kindly provided by Dr Andrew Gates (University of East 
Anglia)68. The expression vector used here was a modified version that has had the GFP marker removed. The 
 His6-tag present in the vector was removed during the ndh2 insertion. The vector was transformed into the 
MFDpir E. coli donor strain and subsequently conjugated into the Pd1222-∆Hy parental  strain35 of P. denitri-
ficans at a 10:1 donor to recipient ratio. After two days of incubation at 30 °C on LB plates containing 0.5 mM 
diaminopimelic acid, successful conjugation was selected for by plating serial dilutions onto LB agar containing 
rifampicin (50 µg  mL–1) and gentamicin (20 µg  mL–1).
Generation of the affinity-tagged complex I strain. The location and design for the affinity tag replicated the 
purification tag previously engineered onto Y. lipolytica complex  I38,39. The affinity tag was designed to contain 
six histidine residues attached to the C-terminus of the Nqo5 subunit by six alanine linker residues. The inser-
tion of the affinity tag onto the C-terminus of the Nqo5 subunit of P. denitrificans complex I was achieved using 
a similar strategy as described previously for creating deletions in the P. denitrificans  genome35,40,41. Insertion 
cassettes were designed containing two sequences homologous to regions on either side of nqo5 (Pden 2248, 
nt 2,250,063–689). The first homologous flanking region of 1292 bp began at nucleotide position 2,248,772 and 
extended to position 2,250,065 to include the STOP codon of the nqo5 gene. The sequence for the  His6Ala6-tag 
(5ʹ-GTG ATG GTG ATG ATG ATG CGC GGC TGC CGC GGC GGC-3ʹ) was then inserted to become the new 
C-terminal sequence of nqo5. The next flanking region contained the entire nqo5 gene (minus the STOP codon) 
and extended for a further 1071 bp to nucleotide position 2,251,760. This second flanking region was followed 
by a kanamycin (kanR) selection marker of 815 bp length. EcoRI restriction sites were added to the end of the 
construct and any EcoRI sites within the construct itself were removed by silent mutagenesis. The construct 
was assembled by GENEWIZ® and then inserted into the lacZ-containing pRVS1 suicide plasmid via an EcoRI 
restriction site. The plasmid was transformed into the MFDpir E.  coli donor strain and conjugated into the 
Pd1222-∆Hy parental strain containing the ndh2 gene on pLMB509. NDH-2 was expressed throughout conju-
gation and homologous recombination by including taurine (10 mM) in all media. Successful conjugation and 
first recombination events were selected by using LB-agar plates containing 50 µg  mL–1 kanamycin. Successful 
colonies were then plated on X-gal (200 µg  mL–1), and white colonies were selected as positive for the second 
recombination event, and screened by PCR amplification of the DNA sequence across the nqo5 gene to confirm 
the expected insertion of base pairs. The integrity of the strain was determined by full sequencing of all complex 
I subunits. Here, we refer to the  His6-tag strain as Pd-Nqo5His6, or as the ‘wild-type’ strain in comparisons with 
the  K232QNqo13 variant.
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Generation of the  K232QNqo13 complex I variant. The  K232QNqo13 complex I variant was created in our Pd-
Nqo5His6 strain that also contained the ndh2 gene on pLMB509. The same procedure as above was followed to 
generate the mutation, ensuring NDH-2 was expressed continuously throughout the protocol by the inclusion of 
10 mM taurine in all media. The point mutation cassettes were designed to include homologous flanking regions 
1000 bp upstream and downstream of nqo13 (Pden_2232). The kanamycin (kanR) selection marker followed 
the second flanking region. The lysine residue in Nqo13 at amino acid position 232 was mutated to a glutamine 
(AAG to CAG). The creation of the mutant was confirmed by sequencing.
Bacterial growth and membrane preparations. Succinate media growth curves. Colonies from the 
Pd-Nqo5His6 strain were picked and grown for 24 h in 40 mL succinate minimal media with/without 10 mM 
taurine (30 °C, 225 rpm); the culture was then used to inoculate 200 µL aliquots of succinate minimal medium 
in a 96-well plate to a starting optical density of 0.02 (at 600  nm). Media were supplemented with/without 
10 mM taurine and with/without 5 µM piericidin A and each experiment was carried out in quadruplicate. 
Plates were incubated at 30 °C with 200 rpm orbital shaking in a CLARIOstar Plus microplate reader (BMG 
Labtech) and the optical density was recorded every 30 min. The minimal medium used was adjusted to pH 7.2 
and contained 50 mM succinate, 9.35 mM  NH4Cl, 2 mM  MgSO4, 0.07 mM  CaCl2, 0.29 mM  KH2PO4, 0.69 mM 
 K2HPO4, 25.2 mM Na-Hepes, 19.6 μM  Na2-EDTA, 9 μM  FeSO4, 0.1 μM  MnCl2, 0.8 μM  CuCl2, 1 μM  Na2MoO4 
and 2.5 μM  ZnCl240,41.
Membrane preparations. Colonies from the Pd-Nqo5His6 strain were picked and grown for 24 h in 50 mL LB 
(30 °C, 225 rpm) then 12 × 500 mL flasks of LB medium were each inoculated with 500 µL of preculture. Flasks 
were grown for 16–20 h (30 °C, 225 rpm) and harvested at late log phase when the  OD600 was 3.5–4.5. Cells were 
collected by centrifugation in a Sorvall RC 12BP centrifuge and resuspended in 2–2.5 mL of buffer per gram of 
cells. The resuspension buffer consisted of 50 mM MES pH 6.5 at 4 °C, 0.002% (w/v) phenylmethanesulfonyl 
fluoride (PMSF) and one cOmplete™ EDTA-free protease inhibitor cocktail (Roche) per 50 mL. After homoge-
nizing the cells, the resuspension was passed through a Z-plus 2.2 kW cell disruptor (Constant Systems Limited) 
once at 15,000 and twice at 30,000 psi. Cell debris was removed by centrifugation at 31,900×g in an SLA-1500 
rotor (Sorvall) for 1 h and the membrane fraction was collected by ultracentrifugation at 234,800×g in a Ti45 
rotor (Beckman) for 2 h. Membranes were suspended in 50 mM MES pH 6.5 at 4 °C and flash frozen in liquid  N2.
Enzyme purifications. P. denitrificans membranes (200–600  mg) were diluted to a concentration of 
9.5 mg  mL–1 in buffer with a composition of 20 mM MES pH 6.5 at 4 °C, 100 mM NaCl, 5 mM  CaCl2, 10% 
glycerol, 0.002% PMSF, and the cOmplete™ EDTA-free protease inhibitor cocktail. Membranes were solubilized 
for 30 min at a 3:1 detergent to protein ratio by addition of 2.85% DDM (Anatrace) to membranes continuously 
stirred at 4 °C. Non-solubilized material was removed by centrifugation (172,000×g, 45 min). Imidazole was 
added to the supernatant to a final concentration of 20 mM, then the supernatant was filtered through a 0.45 µm 
filter. The supernatant was loaded onto either a 2 or 5 mL HisTrap HP column (Cytiva) and washed with buffer 
A (20 mM MES pH 6.5 at 4 °C, 400 mM NaCl, 5 mM  CaCl2, 10% glycerol, 0.1% DDM, 40–80 mM imidazole) 
before complex I was eluted with buffer B (buffer A plus 200 mM imidazole). Fractions from the single eluted 
peak were combined, concentrated to 1 mL, and loaded onto either a Superdex 200 increase 10/300 GL or Super-
dex 200 5/150 GL column (Cytiva) equilibrated in buffer C (20 mM MES pH 6.5 at 4 °C, 150 mM NaCl, 10 mM 
 CaCl2, 10% glycerol, 0.05% DDM). Fractions from the first peak corresponding to complex I were collected and 
concentrated to 10–20 mg  mL–1 before glycerol was added at 20% and the protein flash frozen in liquid  N2.
ATP synthase of E. coli71 and AOX of Trypanosoma brucei brucei61 were purified as described previously.
Membrane and soluble Pd-CI kinetic assays. All kinetic assays were carried out at 32 °C in a Molecu-
lar Devices SpectraMax 348 96-well plate reader in buffer containing 10 mM MES (pH 6.5 at 32 °C), 25 mM 
NaCl and 2  mM  CaCl2. NADH:O2 oxidoreduction was measured at 340–380  nm (ε = 4.81   mM–1   cm–1) and 
NADH:APAD+ (3-acetylpyridine adenine dinucleotide) oxidoreduction was measured at 400–450  nm 
(ε = 3.16  mM–1  cm–1). For NADH:O2 measurements, typically 5–10 µg  mL–1 of membranes were assayed with 
200 µM NADH and 12.5 µg   mL–1 alamethicin. Complex I was inhibited with 5 µM piericidin A. Detergent-
solubilized complex I (0.5 µg  mL–1) was typically assayed for NADH:DQ activity in buffer containing 200 µM 
NADH, 200 µM DQ, 0.15% asolectin, 0.15% CHAPS (3-[(3-cholamidopropyl)dimethylammonio]-1-propane-
sulfonate). The NADH:APAD+ activity of membranes and Pd-CI were assayed in buffer containing 100  µM 
NADH, 500 µM  APAD+ and 1 µM piericidin A. For membranes, 12.5 µg  mL–1 alamethicin was also added to the 
buffer and for Pd-CI, 0.15% asolectin and 0.15% CHAPS were included. dNADH was used for comparison of 
membrane activities for the wild-type and NDH-2 containing variants.  H2O2 production from Pd-CI was meas-
ured at 557–620 nm (ε = 51.6  mM–1  cm–1) using the horseradish peroxidase dependent oxidation of Amplex red 
to  resorufin72. The reaction contained 30 µM NADH, 2 units  mL–1 horseradish peroxidase, 10 µM Amplex red 
and 10 units  mL–1 superoxide dismutase (SOD).
Reconstitution of complex I into liposomes. For a standard reconstitution, 5 mg of synthetic lipids (all 
from Avanti Polar Lipids as 25 mg  mL−1 stocks in chloroform) at a ratio of 52:37:8:3 DOPG:DOPC:DOPE:TOCL 
(% (w/w)), mimicking the natural lipid composition of P. denitrificans  membranes65, and 50 nmol ubiquinone 
 Q10 (from a 6.8 mM stock in chloroform) were mixed in a 25 mL round bottomed flask. For optimization of the 
reconstitution protocol, the total and relative amounts of lipids were varied as described in the figure legends. 
The chloroform was removed by rotating the flask under a nitrogen stream, then further for at least 1 h under 
vacuum in a desiccator. Liposomes were formed by the addition of 1 mL reconstitution buffer (10 mM MES, pH 
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6.5, 50 mM KCl, 250 mM sucrose), to achieve 5 mg lipid  mL−1, and by vigorous mixing (Vortex Genie 2, Scien-
tific Instruments) followed by 11 extrusions through a 100 nm Nucleopore polycarbonate membrane (What-
man). For reconstitution of Pd-CI, 200 µL liposomes (5 mg lipid  mL−1) were partially solubilized by addition of 
6 μL 20% (w/v) sodium cholate (0.5% final concentration) and the solution was incubated for 10 min on ice after 
mixing briefly by inversion. Then, 100 µg purified Pd-CI (13.4 mg  mL−1) (and 50 µg E. coli ATP synthase for co-
reconstitutions) and reconstitution buffer were added to yield a final volume of 250 μL. The solution was mixed 
by inversion, incubated on ice for 15 min, and cholate was removed using a PD10 desalting column (Cytiva) at 
4 °C. PLs were collected by centrifugation at 100,000×g (4 °C for 45 min), resuspended in 100 μL ice-cold recon-
stitution buffer, and stored on ice until required.
Characterization and kinetic assays of proteoliposomes. The amount of Pd-CI in PLs was calcu-
lated using a flavin-site NADH:APAD+ oxidoreduction  assay73. The specific NADH:APAD+ activity of purified 
Pd-CI was measured in reconstitution buffer containing 1 µg   mL–1 Pd-CI, 100 µM NADH, 500 µM  APAD+, 
1 µM piericidin A and 0.2% (w/v) DDM. To calculate the amount of outward facing Pd-CI in PLs, the spe-
cific activity of purified Pd-CI was compared to the activity of PLs in reconstitution buffer containing 100 µM 
NADH, 500 µM  APAD+ and 1 µM piericidin A. Orientation and retention of Pd-CI were determined by add-
ing 20 µg  mL–1  alamethicin61 or 0.2% DDM, respectively, to the assay mixture. The total phospholipid and  Q10 
contents were determined as described  previously61,63. Rates of NADH:O2 oxidoreduction were measured with 
0.5 μg outward-facing CI  mL−1 in the reconstitution buffer containing 200 μM NADH and 20 μg  mL−1 AOX. 
For determination of the respiratory control ratio, an additional 10  µg   mL-1 gramicidin A were used in the 
assay  buffer61. Fluorescence quench assays were conducted in a Shimadzu RF-5301 PC spectrofluorometer as 
described  previously63 using reconstitution buffer containing 1 μg outward facing CI  mL−1, 20 μg AOX  mL−1, 
500 nM ACMA and 5 µM valinomycin. Fluorescence quenches were initiated by addition of 1 mM NADH and 
the ΔpH formed was released by the addition of 25 μg  mL−1 alamethicin. ATP synthesis was measured at ambient 
temperature for 1 μg outward-facing CI  mL−1 as  described63.
EPR spectroscopy. EPR samples were prepared anaerobically by transferring 100 µL of purified complex I 
(5.8 mg  mL–1) to a 4 mm (O.D.) EPR tube (Wilmad), then the complex I was reduced by the addition of 15 mM 
NADH. The sample was immediately frozen in dry-ice/acetone before transfer to liquid nitrogen for storage. 
EPR measurements were performed using an X/Q-band Bruker Elexsys E580 Spectrometer (Bruker BioSpin) 
operating in X-band mode and equipped with a closed-cycle cryostat (Cryogenic Ltd) and X-band split-ring 
resonator module (ER 4118X-MD5). EPR measurement conditions were 100 kHz modulation frequency, 7 G 
modulation amplitude, 2 mW microwave power; other relevant measurement conditions are given in the figure 
legend. All spectra presented are baseline corrected using a buffer-only sample. EPR simulations were performed 
using the EasySpin package for  MATLAB74.
SDS-PAGE and mass spectrometry. Purified complex I was incubated in loading buffer (0.125 M Tris–
HCl (pH 6.8), 20% (w/v) glycerol, 4% (w/v) SDS, 0.005% (w/v) bromophenol blue and 0.1 M DTT) for 10 min 
at room temperature and 10  µg loaded on a Novex WedgeWell 10–20% tris–glycine gel. The gel was run as 
described previously and bands visualized using Coomassie  R25075. Bands excised from SDS-PAGE gels were 
digested with trypsin and analyzed by matrix-assisted laser-desorption ionization (MALDI) using an Applied 
Biosystems spectrometer. Spectra were assigned to peptide sequences and their originating proteins using the 
Mascot 2.4 application (Matrix Science Ltd.) with a peptide precursor mass tolerance of 360 ppm and fragment 
mass tolerance of 0.8 Da. One missed cleavage, plus methionine oxidation and cysteine propionamide formation 
as variable modifications were allowed.
Data availability
All data generated or analyzed during this study are included in this published article (and its Supplementary 
Information files) and/or are available from the corresponding author on reasonable request.
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